|
PLEKHM3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.978800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.983000E-01 |
| Normal-vs-Stage2 |
2.862000E-01 |
| Normal-vs-Stage3 |
9.516000E-01 |
| Normal-vs-Stage4 |
5.544600E-01 |
| Stage1-vs-Stage2 |
2.176800E-01 |
| Stage1-vs-Stage3 |
9.251800E-01 |
| Stage1-vs-Stage4 |
4.113600E-01 |
| Stage2-vs-Stage3 |
3.232200E-01 |
| Stage2-vs-Stage4 |
9.452800E-01 |
| Stage3-vs-Stage4 |
4.917400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.836800E-01 |
| Normal-vs-AfricanAmerican |
3.419000E-01 |
| Normal-vs-Asian |
6.157600E-01 |
| Caucasian-vs-AfricanAmerican |
4.653600E-01 |
| Caucasian-vs-Asian |
6.515400E-01 |
| AfricanAmerican-vs-Asian |
6.491000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.246600E-01 |
| Normal-vs-Female |
7.298100E-02 |
| Male-vs-Female |
6.778500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.537000E-01 |
| Normal-vs-Extreme_Weight |
2.919000E-01 |
| Normal-vs-Obese |
3.997800E-01 |
| Normal-vs-Extreme_Obese |
6.227000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.511600E-01 |
| Normal_Weight-vs-Obese |
4.703800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.624800E-01 |
| Extreme_Weight-vs-Obese |
9.844000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.888600E-01 |
| Obese-vs-Extreme_Obese |
8.944200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.022780E-01 |
| Normal-vs-Age(41-60Yrs) |
1.908200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.002400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.513600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.339000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.959930E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.044600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.144100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.843200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.363750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.688560E-01 |
| Normal-VS-Type2 PRCC |
1.667770E-01 |
| Normal-VS-KIRP CIMP |
1.132190E-01 |
| Normal-VS-Unclassified PRCC |
7.207800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.449690E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.439800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.444800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.740060E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.459620E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.144000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.372800E-01 |
| Normal-vs-N1 |
1.523440E-01 |
| Normal-vs-N2 |
1.008790E-01 |
| N0-vs-N1 |
4.161500E-02 |
| N0-vs-N2 |
2.547200E-01 |
| N1-vs-N2 |
9.833200E-01 |
|
|
